<?xml version="1.0" encoding="UTF-8"?>
<p>Despite existence of intrinsic antitumor activity dsRNA preparations are more frequently studied as synergists and adjuvants to enhance the action of specific therapeutic agents and vaccines. For example, Ayari et al. have shown [
 <xref ref-type="bibr" rid="CR110">110</xref>] that combination of PolyI:PolyC with the Bacillus Calmette-Guérin (BCG) vaccine enhanced the antitumor effect of BCG on bladder cancer transplants in MBT-2 mice. Similar results were obtained by Muthuswamy et al. [
 <xref ref-type="bibr" rid="CR115">115</xref>]; these authors believe that the combined use of BCG with PolyI:PolyC and IFN-α may be a new method for increasing the effectiveness of immunotherapy for bladder cancer.
</p>
